A detailed history of Morgan Stanley transactions in Liquidia Corp stock. As of the latest transaction made, Morgan Stanley holds 533,364 shares of LQDA stock, worth $5.87 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
533,364
Previous 685,439 22.19%
Holding current value
$5.87 Million
Previous $10.1 Million 36.7%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Oct 17, 2024

SELL
$11.96 - $15.71 $1.82 Million - $2.39 Million
-152,075 Reduced 22.19%
533,364 $6.4 Million
Q2 2024

Aug 14, 2024

SELL
$11.96 - $15.71 $1.82 Million - $2.39 Million
-152,075 Reduced 22.19%
533,364 $6.4 Million
Q1 2024

Oct 17, 2024

BUY
$11.35 - $16.73 $1.73 Million - $2.54 Million
152,075 Added 28.51%
685,439 $10.1 Million
Q1 2024

Aug 16, 2024

SELL
$11.35 - $16.73 $3.64 Million - $5.37 Million
-320,918 Reduced 31.89%
685,439 $10.1 Million
Q1 2024

May 15, 2024

SELL
$11.35 - $16.73 $3.64 Million - $5.37 Million
-320,918 Reduced 31.89%
685,439 $10.1 Million
Q4 2023

Aug 16, 2024

BUY
$5.77 - $12.19 $2.73 Million - $5.77 Million
472,993 Added 88.68%
1,006,357 $12.1 Million
Q4 2023

Feb 13, 2024

BUY
$5.77 - $12.19 $3.76 Million - $7.95 Million
652,384 Added 184.3%
1,006,357 $12.1 Million
Q3 2023

Nov 15, 2023

SELL
$6.27 - $8.15 $205,273 - $266,822
-32,739 Reduced 8.47%
353,973 $2.24 Million
Q2 2023

Aug 14, 2023

BUY
$6.63 - $9.9 $1.62 Million - $2.41 Million
243,864 Added 170.72%
386,712 $3.04 Million
Q1 2023

May 15, 2023

SELL
$5.72 - $7.91 $694,270 - $960,084
-121,376 Reduced 45.94%
142,848 $987,000
Q4 2022

Feb 14, 2023

SELL
$4.68 - $6.54 $333,099 - $465,484
-71,175 Reduced 21.22%
264,224 $1.68 Million
Q3 2022

Nov 14, 2022

SELL
$3.73 - $8.39 $254,430 - $572,298
-68,212 Reduced 16.9%
335,399 $1.82 Million
Q2 2022

Oct 27, 2022

SELL
$3.37 - $7.55 $504,310 - $1.13 Million
-149,647 Reduced 27.05%
403,611 $1.76 Million
Q2 2022

Aug 15, 2022

SELL
$3.37 - $7.55 $504,310 - $1.13 Million
-149,647 Reduced 27.05%
403,611 $1.76 Million
Q1 2022

Oct 27, 2022

BUY
$5.14 - $7.38 $769,185 - $1.1 Million
149,647 Added 37.08%
553,258 $3.97 Million
Q1 2022

May 13, 2022

BUY
$5.14 - $7.38 $671,371 - $963,953
130,617 Added 30.9%
553,258 $3.97 Million
Q4 2021

Feb 14, 2022

BUY
$2.71 - $5.17 $447,372 - $853,473
165,082 Added 64.09%
422,641 $2.06 Million
Q3 2021

Nov 15, 2021

BUY
$2.28 - $2.95 $587,234 - $759,799
257,559 New
257,559 $710,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.